Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

A novel PET probe for tumor hypoxia imaging with excellent renal clearance

Sadaaki Kimura, Takuya Kuriyama, Yoshiki Kojima, Izumi Umeda, Noriyuki Moriyama and Hirofumi Fujii
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1714;
Sadaaki Kimura
1National Cancer Center Hospital East, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuya Kuriyama
1National Cancer Center Hospital East, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiki Kojima
1National Cancer Center Hospital East, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Izumi Umeda
1National Cancer Center Hospital East, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriyuki Moriyama
2National Cancer Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirofumi Fujii
1National Cancer Center Hospital East, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1714

Objectives PET for detection of tumor hypoxia considerably contributes to the optimization of cancer therapy. Although 18F-FMISO PET has been performed to detect tumor hypoxia in clinical settings, its excretion rate is too slow to show good contrast between hypoxic tumors and background areas. In this study, we aimed to develop a novel 18F-labeled PET probe for hypoxia imaging with better renal clearance than 18F-FMISO.

Methods Our unique probe was designed using pimonidazole, a radiosensitizer with excellent renal clearance. Our new probe was named 18F-FPINI and was synthesized through the reaction of mesylated pimonidazole with K18F/K2.2.2. Biodistribution of 18F-FPINI in C3H/He mice bearing FM3A tumor was compared with that of 18F-FMISO. Furthermore, their in vivo images were obtained using a PPIS-4800 planar scanner (Hamamatsu Photonics, Japan) for 120 min after intravenous injection.

Results The optimization of the reaction conditions resulted in successful synthesis of 18F-FPINI with satisfactory radiochemical yield (14%-26%, 80-230 GBq/µmol). 18F-FPINI showed good tumor retention and rapid renal excretion (63% of the injected dose was excreted in the urine in 2 h). Biodistribution and renal clearance of 18F-FPINI were more desirable than those of 18F-FMISO for hypoxia imaging, which was retained in muscle, blood, and other organs for a longer duration. In vivo planar images revealed that 18F-FPINI clearly depicted tumor hypoxia at an early stage, whereas 18F-FMISO failed to do so. At 60 min after injection, tumor/muscle (T/M) and tumor/blood (T/B) ratios for 18F-FPINI were 2.10 and 2.40, respectively, whereas those for 18F-FMISO were 1.73 and 2.00, respectively.

Conclusions We successfully synthesized a novel PET probe for hypoxia imaging. 18F-FPINI showed a more rapid renal clearance than the most popular probe 18F-FMISO. 18F-FPINI clearly depicted tumor hypoxia. Therefore, 18F-FPINI would be a promising PET probe for tumor hypoxia

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A novel PET probe for tumor hypoxia imaging with excellent renal clearance
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A novel PET probe for tumor hypoxia imaging with excellent renal clearance
Sadaaki Kimura, Takuya Kuriyama, Yoshiki Kojima, Izumi Umeda, Noriyuki Moriyama, Hirofumi Fujii
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1714;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A novel PET probe for tumor hypoxia imaging with excellent renal clearance
Sadaaki Kimura, Takuya Kuriyama, Yoshiki Kojima, Izumi Umeda, Noriyuki Moriyama, Hirofumi Fujii
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1714;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • A radioactive method for assessing microbial safety of an infusion set for contrast-enhanced imaging
  • Cathepsin K inhibitors for in vivo osteoclast imaging by PET
  • Nonradioactive analytical methods for quantifying the modification ratio of antibody chelator conjugates (ACCs) with deferroxamine and DOTA
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Probes for Oncology Posters

  • PET imaging and quantification of the effects of succinylated gelatin and/or L-lysine on renal uptake and retention of the novel radiopharmaceutical 64Cu-cyclam-RAFT-c(-RGDfK-)4
  • An automatic synthesis module for Ga-68-DOTATATE labeling and compliant with the GMP
  • Radioiodinated indomethacin amides as COX-2-specific SPECT tracers: Synthesis and initial in vitro study
Show more Special MTA: Probes for Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire